Patheon 4Q/FY11 4Q Revenues: $181.6 million (+2%) 4Q Loss: $5.4 million (loss of $900,000 in 4Q10) FY Revenues: $700 million (+4%) FY Loss: $16.8 million (loss of $5.0 million in FY10) Comments: Commercial manufacturing revenues were up 1% in 4Q11 to $146.8 million and +5% for FY11 to$572.6 million. Pharmaceutical development services (PDS) revenues rose 5% in 4Q11 to $34.8 million and +1% to $127.4 million in FY11. FY10 included a non-recurring payment of $11.2 million due to a discontinue...